AI tools generated nearly $1B in extra costs, Blue Cross insurers say

Commenters discuss claims by Blue Cross insurers that AI-enhanced diagnostic-assistance tools - like record scanning and ambient transcription - are generating nearly $1 billion in extra costs by surfacing secondary diagnoses that increase case complexity without producing matching treatment. dTal summarized that insurers allege these secondary labels raise payment levels even when untreated. SpicyLemonZest accepts the insurers’ basic mechanism and says rising costs harm both insurers and consumers. Others, including ulfw and timoshishi, argue the technology’s ROI is overpromised and that doctors or healthcare providers may be the ones benefiting financially while insured patients do not receive more care.

Opinion divides over where blame lies and what the consequences mean. lp92 calls the insurers’ argument a scapegoat to preserve profits, while itopaloglu83 compares the situation to the GameStop episode, suggesting insurers feared a different set of users exploiting existing tools and will lobby for relief. sinuhe69 accuses providers of “milking” insurance via background mining of records, and Rebelgecko frames the outcome as a profitable scaling of industry revenue. cyanydeez offers a broader critique that the U.S. healthcare system is not designed around patient welfare, highlighting tension between financial incentives and patient outcomes.